Hanna C, Etry H, Ibrahim M, Khalife L, Bahous S, Faour W
BMC Nephrol. 2025; 26(1):118.
PMID: 40045253
PMC: 11884025.
DOI: 10.1186/s12882-025-04039-w.
Guo Z, Gao S, Xu F, Chen Z, Wang Q, Liu Z
J Nanobiotechnology. 2025; 23(1):81.
PMID: 39905421
PMC: 11792197.
DOI: 10.1186/s12951-025-03108-4.
Zhang R, Oh J, Wice B, Dusso A, Bernal-Mizrachi C
J Steroid Biochem Mol Biol. 2025; 247:106676.
PMID: 39818342
PMC: 11859504.
DOI: 10.1016/j.jsbmb.2025.106676.
Roye Y, Miller C, Kalejaiye T, Musah S
Matrix Biol Plus. 2024; 24:100164.
PMID: 39582511
PMC: 11585791.
DOI: 10.1016/j.mbplus.2024.100164.
Min L, Chen Y, Zhong F, Gu L, Lee K, He J
Kidney Dis (Basel). 2024; 10(5):398-406.
PMID: 39430290
PMC: 11488836.
DOI: 10.1159/000540452.
Podocyte-Specific Expression of the Stress Response Protein REDD1 Is Necessary for Diabetes-Induced Podocytopenia.
Sunilkumar S, Yerlikaya E, Toro A, Chen H, Zhou Y, Gill D
Diabetes. 2024; 74(3):398-408.
PMID: 39320924
PMC: 11842600.
DOI: 10.2337/db24-0533.
O-linked β-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy.
Qi B, Chen Y, Chai S, Lu X, Kang L
Diabet Med. 2024; 42(2):e15436.
PMID: 39279604
PMC: 11733667.
DOI: 10.1111/dme.15436.
Molecular mechanisms and therapeutic potential of natural flavonoids in diabetic nephropathy: Modulation of intracellular developmental signaling pathways.
Sulaiman M
Curr Res Pharmacol Drug Discov. 2024; 7:100194.
PMID: 39071051
PMC: 11276931.
DOI: 10.1016/j.crphar.2024.100194.
Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy.
Yamashiro A, Satoh Y, Endo S, Oshima N
Hum Cell. 2024; 37(5):1553-1558.
PMID: 39052150
DOI: 10.1007/s13577-024-01108-4.
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)-A Narrative Review.
Iordan L, Gaita L, Timar R, Avram V, Sturza A, Timar B
Int J Mol Sci. 2024; 25(13).
PMID: 39000165
PMC: 11241663.
DOI: 10.3390/ijms25137057.
IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease.
Wang X, Zhang Y, Chi K, Ji Y, Zhang K, Li P
Apoptosis. 2024; 29(7-8):1109-1125.
PMID: 38796567
DOI: 10.1007/s10495-024-01974-1.
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus.
Xu S, Hultstrom M, Larsson A, Lipcsey M, Lindskog C, Bulow S
J Clin Med. 2024; 13(9).
PMID: 38731071
PMC: 11084804.
DOI: 10.3390/jcm13092540.
Podocyte-targeted therapies - progress and future directions.
Meliambro K, He J, Campbell K
Nat Rev Nephrol. 2024; 20(10):643-658.
PMID: 38724717
DOI: 10.1038/s41581-024-00843-z.
Artificial intelligence assists identification and pathologic classification of glomerular lesions in patients with diabetic nephropathy.
Lei Q, Hou X, Liu X, Liang D, Fan Y, Xu F
J Transl Med. 2024; 22(1):397.
PMID: 38684996
PMC: 11059590.
DOI: 10.1186/s12967-024-05221-8.
Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.
Shukla A, Awasthi K, Usman K, Banerjee M
World J Diabetes. 2024; 15(4):606-622.
PMID: 38680697
PMC: 11045416.
DOI: 10.4239/wjd.v15.i4.606.
Jiawei Shengjiangsan's Effect on Renal Injury in Diabetic Nephropathy Mice is Investigated via the PI3K/Akt/NF-κB Signaling Pathway.
Yang C, Huang F, Fang H, Zang Y
Diabetes Metab Syndr Obes. 2024; 17:1687-1698.
PMID: 38629025
PMC: 11020332.
DOI: 10.2147/DMSO.S456205.
Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases.
Fukuda A, Sato Y, Shibata H, Fujimoto S, Wiggins R
Clin Exp Nephrol. 2024; 28(6):496-504.
PMID: 38402504
PMC: 11116200.
DOI: 10.1007/s10157-024-02465-y.
The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression.
Tomita-Yagi A, Ozeki-Okuno N, Watanabe-Uehara N, Komaki K, Umehara M, Sawada-Yamauchi H
iScience. 2024; 27(2):109020.
PMID: 38357667
PMC: 10865398.
DOI: 10.1016/j.isci.2024.109020.
Identification of Senescence-Associated Biomarkers in Diabetic Glomerulopathy Using Integrated Bioinformatics Analysis.
Zhang L, Wang Z, Tang F, Wu M, Pan Y, Bai S
J Diabetes Res. 2024; 2024:5560922.
PMID: 38292407
PMC: 10827377.
DOI: 10.1155/2024/5560922.
[Ketone Body Metabolism and Renal Diseases].
Liu Y, Ma L, Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 54(6):1091-1096.
PMID: 38162055
PMC: 10752776.
DOI: 10.12182/20231160202.